These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 5499122)

  • 21. [The mechanism of the emergence of hematological remissions (on the problem of tumor regression)].
    Alekseev GA
    Ter Arkh; 1968 Apr; 40(4):16-25. PubMed ID: 5740509
    [No Abstract]   [Full Text] [Related]  

  • 22. Alpha interferon in the treatment of hairy cell leukemia.
    Tambone Reyes M; Gebbia V; Teresi M; Bonaccorso R; Colucci A; Quartararo L; Di Marco P; Citarrella P; Mansueto S
    J Chemother; 1989 Jul; 1(4 Suppl):1264-5. PubMed ID: 16312859
    [No Abstract]   [Full Text] [Related]  

  • 23. Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemotherapy.
    Ledzewicz U; Schättler H
    Math Biosci; 2007 Apr; 206(2):320-42. PubMed ID: 16197967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary systemic therapy does not eradicate disseminated tumor cells in breast cancer patients.
    Becker S; Solomayer E; Becker-Pergola G; Wallwiener D; Fehm T
    Breast Cancer Res Treat; 2007 Dec; 106(2):239-43. PubMed ID: 17260094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe, prolonged bone marrow hypoplasia secondary to the use of carboplatin in an azotemic dog.
    Phillips B
    J Am Vet Med Assoc; 1999 Nov; 215(9):1250-2; discussion 1252-3. PubMed ID: 10553432
    [No Abstract]   [Full Text] [Related]  

  • 26. ST1571 (imatinib mesylate) reduces bone marrow cellularity and normalizes morphologic features irrespective of cytogenetic response.
    Hasserjian RP; Boecklin F; Parker S; Chase A; Dhar S; Zaiac M; Olavarria E; Lampert I; Henry K; Apperley JF; Goldman JM
    Am J Clin Pathol; 2002 Mar; 117(3):360-7. PubMed ID: 11888075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study of bone marrow cellularity in selective testing of the anti-tumor action of cytostatic drugs. Determination of the optimum of selectivity].
    Rosin S
    Stud Cercet Med Interna; 1967; 8(1):89-96. PubMed ID: 6043548
    [No Abstract]   [Full Text] [Related]  

  • 28. I have good news! You have leukemia.
    Kurzrock R
    Clin Dermatol; 2007; 25(3):350-2. PubMed ID: 17560314
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of image analysis and immunostaining of bone marrow trephine biopsy specimens to quantify residual disease in patients with B-cell chronic lymphocytic leukemia.
    Gala JL; Guiot Y; Delannoy A; Scheiff JM; Philippe M; Martiat P
    Mod Pathol; 1999 Apr; 12(4):391-9. PubMed ID: 10229504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of secondary myelodysplastic syndromes (MDS) following autologous transplantation should not be based only on morphological criteria used for diagnosis of de novo MDS.
    Amigo ML; del Cañizo MC; Rios A; Garcia MA; Caballero MD; Martin A; Bermejo N; Vilches P; San Miguel JF
    Bone Marrow Transplant; 1999 May; 23(10):997-1002. PubMed ID: 10373064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of minimal residual disease testing during the second year of disease: still no answer?
    Aricò M; Conter V; Valsecchi MG; Masera G
    J Clin Oncol; 2003 Dec; 21(23):4463-4; author reply 4464-5. PubMed ID: 14645441
    [No Abstract]   [Full Text] [Related]  

  • 32. [The role of Thy 1.2(+)-cells in regulation of hematopoiesis during cytostatic depression].
    Zhdanov VV; Aksinenko SG; Dygaĭ AM; Goldberg ED
    Biull Eksp Biol Med; 1998 May; 125(5):509-13. PubMed ID: 9644545
    [No Abstract]   [Full Text] [Related]  

  • 33. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Polycythemia vera as a multiphasic clonal panmyelopathy: diagnostic profile, chronic pathological progression and effect of therapy on the survival of 74 cases].
    Sánchez Fayos J; Prieto E; Román A; Soto de Ozaeta C; Nevado I; Richart A; Chica E; Loscertales J; Calabuig T; Benítez J; Outeiriño J
    Sangre (Barc); 1996 Dec; 41(6):447-57. PubMed ID: 9148422
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor seeding associated with bone marrow aspiration and biopsy.
    Citron ML; Krasnow SH; Grant C; Cohen MH
    Arch Intern Med; 1984 Jan; 144(1):177. PubMed ID: 6318678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Various histological aspects of the bone marrow in Hodgkin's disease].
    Macavei J; Simu G
    Arch Geschwulstforsch; 1970; 35(4):384-91. PubMed ID: 5518345
    [No Abstract]   [Full Text] [Related]  

  • 37. [Histomorphometric study of the bone tissue in patients with chronic renal failure during conservative treatment].
    Adamiec R
    Pol Tyg Lek; 1980 Jun; 35(24):297-900. PubMed ID: 7413511
    [No Abstract]   [Full Text] [Related]  

  • 38. Massive bone marrow necrosis in a patient with chronic myelocytic leukemia following imatinib mesylate therapy.
    Tamura T; Tasaka T; Fujimoto M; Matsuhashi Y; Fukumot T; Mano S; Kuwajima M; Nagai M
    Haematologica; 2004 Sep; 89(9):ECR32. PubMed ID: 15377484
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteoclastogenesis in iliac bone marrow of patients with rheumatoid arthritis.
    Toritsuka Y; Nakamura N; Lee SB; Hashimoto J; Yasui N; Shino K; Ochi T
    J Rheumatol; 1997 Sep; 24(9):1690-6. PubMed ID: 9292789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical contribution to the course of plasmocytoma].
    Kettner W
    Dtsch Gesundheitsw; 1968 Dec; 23(51):2401-3. PubMed ID: 5716261
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.